Progress in the maturity of the start-ups: the clinical phases

by GENESIS Biomed

3 years ago
start-ups, Oxolife, Peptomyc, aptaTargets, GENESIS Biomed, clinical phases, drug

The start-ups Oxolife, Peptomyc and aptaTargets, with which GENESIS Biomed collaborates, are advancing in their maturity with the initiation and development of clinical phases and are approaching an e...

Interview Andreu Climent – Associate Founder and CEO of Corify Care

by GENESIS Biomed

3 years ago
Andreu Climent, GENESIS Biomed, Corify Care

Andreu Climent: “Every time our device is used on a patient, and the patient is cured, it is an incredible adrenaline rush”

Los retos de la sanidad

by GENESIS Biomed

3 years ago
GENESIS Biomed, Sanidad

Hoy publicamos en nuestra web este vídeo en que os acercamos las enseñanzas y consejos que nos ha ofrecido Lluís Triquell, consultor independiente de Salud y miembro del Business Advisory Board GEN...

A FECYT report concludes that the entire innovation incentive scheme needs to be redesigned

by GENESIS Biomed

3 years ago
THINK TANK, FECYT, industrial and intellectual protection

GENESIS Biomed has participated in the preparation of the THINK TANK report “Patenting and/or publishing” by the FECYT, which covers the debate on publishing research or its transfer and exploitat...

Corify Care raises €2.35M to translate its cardiac mapping technology to the market

by GENESIS Biomed

3 years ago
Corify Care, Genesis Biomed, cardiac mapping, technology

Corify Care is developing ACORYS®, a non-invasive cardiac mapping medical device to transform the cardiac arrhythmia treatment process.

Interview Dr. Manuel Desco – Professor of Radiology at the Carlos III University and Head of Experimental Medicine and Surgery at the Gregorio Marañón Hospital

by GENESIS Biomed

3 years ago
GENESIS Biomed, technology, biomedical imaging, biomedical engineering, Manuel Desco

Manuel Desco has the Degree and PhD in Medicine and is Nuclear Medicine Specialist and Telecommunications Engineer. He is currently Professor of Bioengineering at the Carlos III University and Head of...

Nace Endolipid Therapeutics, la spin-off de Vall d’Hebron y GENESIS Ventures que desarrolla una nueva estrategia para reducir la grasa visceral y subcutánea

by GENESIS Biomed

3 years ago
dieta saludable, Endolipid Therapeutics, grasa visceral

La acumulación de grasa ectópica y especialmente en el abdomen (grasa visceral) es un factor independiente de riesgo cardiovascular y también se asocia a hígado graso no alcohólico, una condici...

Algorithms and Image Biomarkers. Radiomics as another piece of precision oncology

by GENESIS Biomed

3 years ago
precision oncology, Image Biomarkers, Radiomics, Cancer

Cancer is a disease with a high incidence rate among the population (442.4 cases per 100,000 people). And its mortality rate stands at 158.3 per 100,000 people. By 2040, the number of new cancer cases...

GENESIS Biomed 4th Anniversary

by GENESIS Biomed

3 years ago
GENESIS Biomed, biomedical research

GENESIS Biomed is celebrating its anniversary. We have been working for 4 years to transfer the results of biomedical research to the market.

Julio Mayol:'Research is one of the key points in the response to this pandemic'

by GENESIS Biomed

3 years ago
Julio Mayol, GENESIS Biomed, pandemic, hospitals

Interview Julio Mayol – Professor of Surgery at the Complutense University of Madrid and Medical Director of the San Carlos Clinical Hospital

Liberalización de las patentes de vacunas contra la COVID

by GENESIS Biomed

3 years ago
GENESIS Biomed, vacunas, patentes, Covid19

Artículo de Opinión de Bernabé Zea – Partner en ZBM Patents & Trademarks y miembro del Business Advisory Board de GENESIS Biomed

The Gregorio Marañón Hospital creates a spin-off to market the drug that protects the kidney

by GENESIS Biomed

3 years ago
Cilastatin project, kidney, Telara Pharma, GENESIS Biomed

The Cilastatin project arose thanks to the research carried out by the deceased Dr. Alberto Tejedor, who was Nephrology Service section chief at the Gregorio Marañón General University Hospital and ...